Esophageal squamous cell carcinoma (ESCC) is one of the most common devasting tumor around the world, characterized by persistent hypoxia. Hypoxia-inducible factor-2α (hif-2α) has been regarded as an oncogene in many kinds of cancers, exerting its function to promote tumor growth and metastasis. But the role of hif-2α in ESCC remains largely unknown. In this study, we discovered hif-2α was overexpressed in ESCC and could promote proliferation and metastasis in ESCC cells. Functionally, hif-2α facilitated EMT through Notch pathway in ESCC. Moreover, we identified hif-2α as an independent factor that predict poor prognosis in ESCC patients. These findings suggested that hif-2α is a key regulator of EMT and played a critical role in promoting ESCC progression.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6
Loading...
Posted 03 Jun, 2021
Posted 03 Jun, 2021
Esophageal squamous cell carcinoma (ESCC) is one of the most common devasting tumor around the world, characterized by persistent hypoxia. Hypoxia-inducible factor-2α (hif-2α) has been regarded as an oncogene in many kinds of cancers, exerting its function to promote tumor growth and metastasis. But the role of hif-2α in ESCC remains largely unknown. In this study, we discovered hif-2α was overexpressed in ESCC and could promote proliferation and metastasis in ESCC cells. Functionally, hif-2α facilitated EMT through Notch pathway in ESCC. Moreover, we identified hif-2α as an independent factor that predict poor prognosis in ESCC patients. These findings suggested that hif-2α is a key regulator of EMT and played a critical role in promoting ESCC progression.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6
Loading...